Search results
Mar 15, 2024 · BENGALURU, India , March 15, 2024 /PRNewswire/ -- Pandorum Technologies, a leading biotechnology company, announced today the successful closure of a pre-Series B funding round, securing USD 11...
Amidst the chaos of Pandemic and vaccine development for COVID-19, Pandorum aspires to give post-trauma treatment for lung regeneration. We are developing a cell-free, safe treatment to repair the damage caused by inflammation and fibrosis. Our exosomal therapy will alleviate lung damage. About Pandorum. Our science.
Mar 19, 2024 · Pandorum Technologies has closed on $11 million following a pre-Series B funding round in support of clinical advancement for its flagship product. Give me the rundown on Pandorum.
Bengaluru-based biotech startup Pandorum Technologies is raising USD 8 million (INR 64.8 crore) in a fresh funding round from Ashish Kacholia, Everest Finance and Investment Company – the finance arm of Everest Foods, among others.
Pandorum Technology is a tissue engineering and regenerative medicine company that uses the foundational and translational principles of biology and engineering to design world class therapeutic products, that aim to alleviate the health conditions of patient’s suffering from on corneal dystrophies, lung related disorders and liver diseases.
Sep 7, 2020 · Pandorum has raised more than INR 41 Cr by issuing Pre-Series B Cumulative Compulsorily Convertible Preference Shares (CCCPS) to several entities. The investors include BTB Ventures and Karnataka...
People also ask
What happened to Pandorum technologies?
What is Pandorum Technology?
Who invested in Pandorum technologies?
What sets Pandorum apart?
May 4, 2019 · Now, scientists at Pandorum Technologies have achieved a new milestone, having bio-engineered human cornea tissue to enable scarless healing of corneal wounds and help restore vision...
